Yang’s group found that combining serum CEACAM1 with CA15-3 increased the diagnostic accuracy of AUC to 0.940 (sensitivity 0.79; specificity 0.97) when CEACAM1 was used with CA15-3 for breast cancer. The gene discussed is CEACAM1; the disease is breast cancer.